News

Is aTyr Pharma, Inc. (ATYR) the Low Risk High Reward Stock Set to Triple by 2030?
We recently published a list of 10 Low Risk High Reward Stocks Set to Triple by 2030. In this article, we are going to take a ...
The Foundation for Sarcoidosis Research Expands Board of Directors with Leaders to Help Accelerate Sarcoidosis Research, Advocacy and Patient Support
The Foundation for Sarcoidosis Research (FSR) is pleased to announce the appointment of four new members to its Board of ...
Tulisa sips on champagne in a white and black ensemble as she watches Chester races on Ladies Day
Tulisa put on a leggy display as she attended Ladies Day at Chester Races on Thursday. The N-Dubz singer, 36, looked nothing ...
aTyr Pharma Announces First Quarter 2025 Results and Provides Corporate Update
Topline data from Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis on track for the third quarter of 2025.
Silicosarcoidosis: Researchers coin new term to define distinct occupational lung disease
In a study led by a multinational team of experts, researchers at National Jewish Health and their collaborators in Colorado, ...
Mirage News1d
Researchers Coin Silicosarcoidosis for New Lung Disease
In a groundbreaking study led by a multinational team of experts, researchers at National Jewish Health and their collaborators in Colorado, Illinois ...
Medscape2d
Slow Burn: Wildfires Have Lasting Effects on Lung Health
As the effects of wildfires persist in several parts of the United States, McGowan highlighted a public health alert ...